Streetbeat News

Partnerships

WY

Weyerhaeuser Company (NYSE:WY) has received approval from the American Carbon Registry for its Improved Forest Management (IFM) carbon credit project in Maine. The project is expected to generate 475,000 credits over its lifetime. Weyerhaeuser is also developing several other IFM projects within its 11-million-acre land base in the U.S., with two slated for completion in late 2023 or early 2024. The company is working with Carbon Direct to ensure the quality of the credits.

Portfolio Pulse from Happy Mohamed

September 20, 2023 | 8:33 pm

CBRE

CBRE Group has entered into a partnership with Emitwise to collect greenhouse gas emissions data. This collaboration aims to help CBRE's clients reduce their carbon footprint by providing them with accurate and timely emissions data.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:09 pm

AIR

AAR Corp. has signed an exclusive multi-year foreign military distribution agreement with Pall Corporation. The terms of the agreement were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:08 pm

IVA

Inventiva (NASDAQ:IVA) and Hepalys Pharma, Inc. have entered into an exclusive licensing agreement to develop and commercialize Inventiva's drug candidate lanifibranor in Japan and South Korea. Inventiva will receive a $10 million upfront payment and is eligible to receive up to $231 million in milestone payments. Inventiva has a 30% ownership in Hepalys Pharma and the option to acquire all outstanding shares of Hepalys Pharma.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:01 pm

ALPMY

TSHA

Astellas Pharma has decided not to exercise its option to obtain an exclusive license to TSHA-120 under the Option Agreement with Taysha Gene Therapies. This decision comes after Taysha submitted a new comprehensive analysis to the FDA in June 2023, with the FDA recommending a randomized, double-blind, placebo-controlled trial as the optimal path to demonstrate efficacy in TSHA-120. Following this, Taysha's shares fell by 6.13%.

Portfolio Pulse from Vandana Singh

September 20, 2023 | 6:12 pm

STLA

The United Auto Workers (UAW) union has announced that Stellantis has made a new contract offer. The details of the offer have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 6:09 pm

ORCL

TSLA

Oracle Corp's co-founder and Executive Chairman Larry Ellison announced plans to use Tesla's Cybertruck for Oracle's next-generation police vehicle. Ellison expressed enthusiasm for the Cybertruck, hinting at undisclosed features and capabilities that make it an ideal choice for Oracle's needs. The vehicle's design, electric powertrain, and advanced technology could align with the security and performance requirements of a police vehicle.

Portfolio Pulse from Benzinga EV Insights

September 20, 2023 | 6:02 pm

WW

Oprah Winfrey, in collaboration with the CEO of Weight Watchers, is presenting at a conference titled 'The State of Weight'.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 5:28 pm

CBAUF

CMWAY

TSLA

Tesla has partnered with the Commonwealth Bank Of Australia to streamline financing for customers interested in electric vehicles. Customers can apply for CBA's financing loans directly through Tesla's website. The loans have a fixed, low rate of 5.49% for eligible sustainable purchases, including electric and hybrid vehicles.

Portfolio Pulse from Nabaparna Bhattacharya

September 20, 2023 | 5:06 pm

EVAX

Evaxion Biotech (NASDAQ:EVAX) has partnered with Afrigen Biologics to develop a prophylactic vaccine based on Evaxion's EDEN-discovered gonorrhea targets. The partnership aims to address a serious global medical need as there is currently no vaccine for gonorrhea. The EDEN-discovered antigens have shown high levels of protection in preclinical studies. The partners will negotiate a subsequent agreement for clinical development and commercialization after the validation phase. Evaxion Biotech also initiated a new pipeline program, EVX-B3, in collaboration with an undisclosed pharmaceutical company.

Portfolio Pulse from Vandana Singh

September 20, 2023 | 5:03 pm